Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
3326
DELISTED
Unity Biotechnology
UBX
| $75.1K | ﹤0.01% |
76,911
-16,759
| -18% | -$20.8K |
|
3327
Armata Pharmaceuticals
ARMP
$177M
| $74.5K | ﹤0.01% |
40,291
-6,205
| -13% | -$13.9K |
|
|
TPIC
3328
DELISTED
TPI Composites
TPIC
| $74.3K | ﹤0.01% |
39,286
-70,400
| -64% | -$196K |
|
3329
Invivyd
IVVD
$202M
| $74.1K | ﹤0.01% |
+167,200
| New | +$130K |
|
|
KORE
3330
DELISTED
KORE Group Holdings
KORE
| $72.9K | ﹤0.01% |
22,641
+700
| +3% | +$1.31K |
|
|
FORA
3331
DELISTED
Forian
FORA
| $72.7K | ﹤0.01% |
35,301
+11,601
| +49% | +$24.1K |
|
3332
Urban One Class A
UONE
$23.5M
| $72.4K | ﹤0.01% |
4,700
-50
| -1% | -$757 |
|
|
NWTG
3333
Newton Golf Co
NWTG
$6.06M
| $72.3K | ﹤0.01% |
+5,743
| New | +$279K |
|
3334
DarioHealth
DRIO
$71.5M
| $72.1K | ﹤0.01% |
4,585
+200
| +5% | +$3.46K |
|
3335
MiNK Therapeutics
INKT
$54.8M
| $70.9K | ﹤0.01% |
10,171
-498
| -5% | -$3.39K |
|
3336
Direxion Daily NVDA Bear 1X ETF
NVDD
$19.4M
| $70.5K | ﹤0.01% |
+1,090
| New | +$70K |
|
3337
Westwater Resources
WWR
$75.2M
| $70.3K | ﹤0.01% |
99,201
+83,611
| +536% | +$48.1K |
|
|
PDC
3338
Perpetuals.com Ltd
PDC
$21.5M
| $70.2K | ﹤0.01% |
+26,400
| New | +$73.3K |
|
|
RPT
3339
Rithm Property Trust
RPT
$101M
| $70.1K | ﹤0.01% |
3,933
+92
| +2% | +$1.69K |
|
|
DMRA
3340
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
| $70K | ﹤0.01% |
15,044
-6,338
| -30% | -$41.5K |
|
3341
RPC Inc
RES
$1.39B
| $68.3K | ﹤0.01% |
+11,500
| New | +$71.3K |
|
|
HOOK
3342
DELISTED
HOOKIPA Pharma
HOOK
| $68.3K | ﹤0.01% |
33,970
+2,500
| +8% | +$7.74K |
|
3343
Amplify Energy
AMPY
$200M
| $67.8K | ﹤0.01% |
11,300
-130,700
| -92% | -$855K |
|
3344
ARKO Corp
ARKO
$505M
| $67.2K | ﹤0.01% |
10,200
-1,300
| -11% | -$8.95K |
|
3345
TriSalus Life Sciences
TLSI
$347M
| $67.1K | ﹤0.01% |
+13,400
| New | +$56.6K |
|
|
CISO
3346
CISO Global
CISO
$12.2M
| $66.6K | ﹤0.01% |
19,200
+2,100
| +12% | +$2.6K |
|
3347
SHF Holdings
SHFS
$2.13M
| $66.6K | ﹤0.01% |
7,397
+5,968
| +418% | +$50.1K |
|
3348
Tango Therapeutics
TNGX
$4.32B
| $66.4K | ﹤0.01% |
+21,500
| New | +$99.8K |
|
3349
Stran & Co
SWAG
$36.3M
| $66.1K | ﹤0.01% |
73,384
+39,753
| +118% | +$42.8K |
|
3350
SkinHealth Systems
SKIN
$85.9M
| $64.2K | ﹤0.01% |
+40,391
| New | +$63.5K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.